Whether you’re racing to launch a new drug or rushing to protect your intellectual property, time is of the essence. The life sciences lawyers at Morningstar Law Group understand the importance of working with speed and efficiency and have the industry knowledge to help clients successfully navigate the drug approval process and commercialize their products.
We assist pharmaceutical companies, CMOs, CROs, biotech firms, agribusinesses, medical device manufacturers and others with complex and strategic legal issues, including intellectual property and corporate law needs. This includes everything from joint ventures and technology transfers to venture capital financings and corporate governance issues. Our attorneys also serve as outside general counsel for emerging life sciences companies.
If you are developing, manufacturing or commercializing a new drug — branded or generic — our life sciences attorneys can prepare the licensing and business agreements necessary to protect your business and minimize risk. This includes development agreements, supply and distribution agreements, collaboration agreements, royalty monetization agreements, and more.
Every industry faces unique legal challenges. We have an in-depth understanding of the life sciences industry and work closely with firms of all sizes, from startups to publicly-traded Fortune 500 companies, to help you efficiently protect and commercialize products.